Sam Waksal seeks ‘redemption’ with Imclone II (Morning Read)
Samuel D. Waksal, the former chief executive of biotechnology company ImClone Systems who spent five years in federal prison for insider trading is mounting an audacious effort at redemption, again in biotechnology, the New York Times reports.